To search for targets of therapy that changes the course of Parkinson’s disease

Authors

  • V.V. Ponomarev Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus, Belarus
  • A.V. Boika Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus, Belarus
  • Sialitski Sialitski Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus, Belarus
  • V.A. Bahamaz Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus, Ukraine

DOI:

https://doi.org/10.22141/2224-0713.17.6.2021.242229

Keywords:

Parkinson’s disease, precipitating factors, stress, pain syndrome, autowave penumbra, depolarization wave, therapy criteria

Abstract

Background. Parkinson’s disease (PD) is a multisystem disease that requires a more comprehensive approach to its study and treatment. The purpose was to give clinical and laboratory characteristics of PD patients, in whom the onset of motor symptoms of the disease is associated with the action of precipitating factors and provide a theoretical justification for the underlying and/or associated electrophysiological phenomena. Materials and me-thods. Two hundred and seven patients with PD were examined. Questionnaire analysis and laboratory research were performed. Results. Among patients with a rapidly progressive type of PD, pain during the survey was registered in 49 (42.2 %) cases, and stress in 73 (62.3 %). In cases of a slowly progressive course, 14 (15.4 %) individuals experienced pain syndromes, and 53 (58.2 %) patients — stress. Statistically significant differences between patients with rapidly and slowly progressive PD courses were noted in the number of cases of herpetic diseases, inflammatory diseases of the oral cavity. The results of laboratory tests also showed statistically significant differences between these groups in the blood serum level of IL1β and cortisol, the level of IL1β in the cerebrospinal fluid, and the albumin coefficient. The patients with a rapidly progressive type of disease presented with a greater number of precipitating factors for PD development. In patients with rapidly progressive PD, the number of precipitating factors and the serum level of antibodies to α-synuclein (r = –0.18), IL10 (r = 0.31), and cortisol (r = 0.18) correlated. Some objective characteristics of non-motor PD symptoms statistically significantly correlated with a level of laboratory biomarkers in blood serum (Montreal Cognitive Assessment value with cortisol level (r = –0.4); Pittsburgh Sleep Quality Index value with antibodies to α-synuclein (r = 0.31); Epworth Sleepiness Scale value with IL10 level (r = –0.21)). Significant acute psychological stresses and pain syndromes may change the pattern of propagation of depolarization waves in the nervous system with the formation of “autowave penumbra”. Possible clinical criteria for the effectiveness of therapy that change the course of PD are presented. Conclusions. Pain syndromes and acute significant psychological stresses not only contribute to the onset of motor symptoms of PD but also lead to the rapid progression of the disease. The effect of precipitating factors may manifest itself not only in clinical, morphological, and laboratory changes but also in changes in the excitability of nerve cells. The electrophysiological penumbra (“autowave penumbra”) can be considered a possible target for the action of a therapy method that modifies the course of PD.

References

Harms A.S., Ferreira S.A., Romero-Ramos M. Periphery and brain, innate and adaptive immunity in Parkinson’s disease. Acta Neuropathologica. 2021. Vol. 141, 4. P. 527-545. doi: 10.1007/s00401-021-02268-5.

Kouli A., Torsney K.M., Kuan W.L. Parkinson’s Disease: Etio-logy, Neuropathology, and Pathogenesis. Chapter 1. Parkinson’s Dise-ase: Pathogenesis and Clinical Aspects [Internet]. In: Stoker T.B., Greenland J.C., editors. Brisbane (AU): Codon Publications, 2018. Available from: https://www.ncbi.nlm.nih.gov/books/NBK536722/ doi: 10.15586/codonpublications.parkinsonsdisease.2018.ch1.

Oertel W., Schulz J.B. Current and experimental treatments of Parkinson disease: A guide for neuroscientists. J. Neurochem. 2016. Vol. 139, Suppl. 1. P. 325-337. doi: 10.1111/jnc.13750.

Dauer W., Przedborski S. Parkinson’s disease: mechanisms and models. Neuron. 2003. Vol. 39, 6. P. 889-909. doi: 10.1016/s0896-6273(03)00568-3.

Fearnley J.M., Lees A.J. Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain. 1991. Vol. 114. P. 2283-2301. doi: 10.1093/brain/114.5.2283.

Boika A.V. Provocirujushhie faktory debjuta motornyh simptomov bolezni Parkinsona. Mezhdunarodnyj Nevrologicheskij Zhurnal. 2017. 5 (91). P. 15-20.

Yapici-Eser H., Donmez-Demir B., Kilic K. et al. Stress modulates cortical excitability via alpha-2 adrenergic and glucocorticoid receptors: As assessed by spreading depression. Exp. Neurol. 2018. Vol. 307. P. 45-51. doi: 10.1016/j.expneurol.2018.05.024.

Chiu I.M., von Hehn C.A., Woolf C.J. Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology. Nat. Neurosci. 2012. Vol. 15, 8. P. 1063-1067. doi: 10.1038/nn.3144.

Chiu I.M., Pinho-Ribeiro F.A., Woolf C.J. Pain and infection: pathogen detection by nociceptors. Pain. 2016. Vol. 157, 6. P. 1192-1193. doi: 10.1097/j.pain.0000000000000559.

Pinho-Ribeiro F.A., Verri W.A. Jr., Chiu I.M. Nociceptor Sensory Neuron-Immune Interactions in Pain and Inflammation. Trends Immunol. 2017. Vol. 38, 1. P. 5-19. doi: 10.1016/j.it.2016.10.001.

Michel P.P., Hirsch E.C., Hunot S. Understanding dopaminergic cell death pathways in Parkinson disease. Neuron. 2016. Vol. 90, 4. P. 675-691. doi: 10.1016/j.neuron.2016.03.038.

Alberico S.L., Cassell M.D., Narayanan N.S. The vulnerable ventral tegmental area in Parkinson’s disease. Basal Ganglia. 2015. Vol. 5, 2–3. P. 51-55. doi: 10.1016/j.baga.2015.06.001.

Ridding M.C., Inzelberg R., Rothwell J.C. Changes in ­excitability of motor cortical circuitry in patients with Parkinson’s disease. Ann. Neurol. 1995. Vol. 37, 2. P. 181-188. doi: 10.1002/ana.410370208.

Vucic S., Kiernan M.C. Transcranial magnetic stimulation for the assessment of neurodegenerative disease. Neurotherapeutics. 2017. Vol. 14, 1. P. 91-106. doi: 10.1007/s13311-016-0487-6.

Bozzi Y., Provenzano G., Casarosa S. Neurobiological bases of autism-epilepsy comorbidity: a focus on excitation/inhibition imba-lance. Eur. J. Neurosci. 2018. Vol. 47, 6. P. 534-548. doi: 10.1111/ejn.13595.

Foss-Feig J.H., Adkinson B.D., Ji J.L. et al. Searching for Cross-Diagnostic Convergence: Neural Mechanisms Governing ­Excitation and Inhibition Balance in Schizophrenia and Autism Spectrum Disorders. Biol. Psychiatry. 2017. Vol. 81, 10. P. 848-861. doi: 10.1016/j.biopsych.2017.03.005.

De Pablos R.M., Herrera A.J., Espinosa-Oliva A.M. et al. Chronic stress enhances microglia activation and exacerbates death of nigral dopaminergic neurons under conditions of inflammation. J. Neuroinflammation. 2014. Vol. 24, 11. P. 34. doi: 10.1186/1742-2094-11-34.

Smith A.D., Castro S.L., Zigmond M.J. Stress-induced Parkinson’s disease: a working hypothesis. Physiol. Behav. 2002. Vol. 77, 4–5. P. 527-31. doi: 10.1016/s0031-9384(02)00939-3.

Schabrun S.M., Burns E., Thapa T., Hodges P. The response of the primary motor cortex to neuromodulation is altered in chro-nic low back pain: a preliminary study. Pain Med. 2018. Vol. 19, 6. P. 1227-1236. doi: 10.1093/pm/pnx168.

Thibaut A., Zeng D., Caumo W. et al. Corticospinal exci-tability as a biomarker of myofascial pain syndrome. Pain Rep. 2017. Vol. 2, 3. e594. doi: 10.1097/PR9.0000000000000594.

Cosentino G., Fierro B., Vigneri S. et al. Cyclical changes of cortical excitability and metaplasticity in migraine: evidence from a repetitive transcranial magnetic stimulation study. Pain. 2014. Vol. 155, 6. P. 1070-1078. doi: 10.1016/j.pain.2014.02.024.

Castillo Saavedra L., Mendonca M., Fregni F. Role of the primary motor cortex in the maintenance and treatment of pain in fibromyalgia. Med. Hypotheses. 2014. Vol. 83, 3. P. 332-336. doi: 10.1016/j.mehy.2014.06.007.

De Iure A., Napolitano F., Beck G. et al. Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior. Mov. Disord. 2019. Vol. 34, 6. P. 832-844. doi: 10.1002/mds.27632.

Leão A.A.P. Spreading depression of activity in the cerebral cortex. J. Neurophysiol. 1944. doi: 10.1152/jn.1944.7.6.359.

Pietrobon D., Moskowitz M.A. Chaos and commotion in the wake of cortical spreading depression and spreading depolarizations. Nat. Rev. Neurosci. 2014. Vol. 15, 6. P. 379-93. doi: 10.1038/nrn3770.

Taş Y.Ç., Solaroğlu İ., Gürsoy-Özdemir Y. Spreading Depolarization Waves in Neurological Diseases: A Short Review about its Pathophysiology and Clinical Relevance. Curr. Neuropharmacol. 2019. Vol. 17, 2. P. 151-164. doi: 10.2174/1570159X15666170915160707.

Hertelendy P., Varga D.P., Menyhárt Á. et al. Susceptibility of the cerebral cortex to spreading depolarization in neurological disease states: The impact of aging. Neurochem. Int. 2019. Vol. 127. P. 125-136. doi: 10.1016/j.neuint.2018.10.010.

Lauritzen M., Dreier J.P., Fabricius M. et al. Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J. Cereb. Blood Flow Metab. 2011. Vol. 31, 1. P. 17-35. doi: 10.1038/jcbfm.2010.191.

Vasiliev V.A., Romanovskii Yu.M., Chernavskii D.S., Yakhno V.G. Autowave Processes in Kinetic Systems. Spatial and Temporal Self-Organization in Physics, Chemistry, Biology and Medicine. D. Reidel Publishing Company. Dordrecht/Boston/Lancaster/ Tokyo, 1987. P. 262.

Robertson R.M., Dawson-Scully K.D., Andrew R.D. Neural shutdown under stress: an evolutionary perspective on spreading depolarization. J. Neurophysiol. 2020. Vol. 123, 3. P. 885-895. doi: 10.1152/jn.00724.2019.

Bae J.S., Menon P., Mioshi E. et al. Cortical hyperexcitabi-lity and the split-hand plus phenomenon: pathophysiological insights in ALS. Amyotroph. Lateral Scler. Frontotemporal Degener. 2014. Vol. 15, 3–4. P. 250-256. doi: 10.3109/21678421.2013.872150. Epub 2014 Feb 20.

Downloads

Published

2021-11-23

Issue

Section

Original Researches